Article thumbnail

Changes in Gene Expression and Cellular Architecture in an Ovarian Cancer Progression Model

By Amy L. Creekmore, William T. Silkworth, Daniela Cimini, Roderick V. Jensen, Paul C. Roberts and Eva M. Schmelz
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3048403
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). A
  2. (2007). A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
  3. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.
  4. (2004). Actin and microtubules in cell motility: which one is in control?
  5. (2004). actin filaments during cell polarization and migration.
  6. (2001). Actin-dependent membrane association of the APC tumour suppressor in polarized mammalian epithelial cells.
  7. (2011). Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
  8. (2006). Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.
  9. (2008). Alpha-actinin structure and regulation.
  10. (2001). Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray.
  11. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
  12. (1981). Are stress fibres contractile?
  13. (2006). Balancing cell adhesion and Wnt signaling, the key role of beta-catenin.
  14. (2004). Cancer of the ovary.
  15. (2009). Cancer statistics,
  16. (2007). Cell motility and cytoskeletal regulation in invasion and metastasis.
  17. (2009). Combination of enzastaurin and pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylation.
  18. (2007). Comparative proteome analysis of human epithelial ovarian cancer.
  19. (2007). Computation of significance scores of unweighted Gene Set Enrichment Analyses.
  20. (2004). Control of motile and invasive cell phenotypes by focal adhesion kinase.
  21. (2003). cPKC-dependent sequestration of membranerecycling components in a subset of recycling endosomes.
  22. (1996). Cytoskeletal architecture in mouse lung epithelial cells is regulated by proteinkinase C-alpha and calpain II.
  23. (2006). Cytoskeleton out of the cupboard: colon cancer and cytoskeletal changes induced by loss of APC.
  24. (2003). Data reduction and error analysis for the physical sciences. Boston: McGraw-Hill xi, 320 p. Cytoskeleton Changes
  25. (2005). Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling.
  26. (2010). DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC.
  27. (2006). Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
  28. (2005). Expression profiling of serous low malignant potential, low-grade, and highgrade tumors of the ovary.
  29. (2006). Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.
  30. (2005). Focal adhesion kinase: in command and control of cell motility.
  31. (2002). Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.
  32. (2007). GeneTrail– advanced gene set enrichment analysis.
  33. (2007). Identification of candidate methylation-responsive genes in ovarian cancer.
  34. (2008). Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT).
  35. (1995). Immunocytochemical localization of eight protein kinase C isozymes overexpressed in NIH 3T3 fibroblasts. Isoform-specific association with microfilaments, Golgi, endoplasmic reticulum, and nuclear and cell membranes.
  36. (2004). Implications of cytokeratin 8/18 filament formation in stratified epithelial cells: induction of transformed phenotype.
  37. (2008). Interference with actin dynamics is superior to disturbance of microtubule function in the inhibition of human ovarian cancer cell motility.
  38. (2008). Intracellular transport and kinesin superfamily proteins, KIFs: structure, function, and dynamics.
  39. (2007). Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis.
  40. (2010). Microtubule assembly by the Apc protein is regulated by importin-beta– RanGTP.
  41. (2009). Microtubule stabilising agents for cancer chemotherapy.
  42. (2005). Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential.
  43. (2009). Novel association of APC with intermediate filaments identified using a new versatile APC antibody.
  44. (2009). Nuclear APC.
  45. (2003). Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate.
  46. (2004). Onto-Tools: an ensemble of web-accessible, ontology-based tools for the functional design and interpretation of high-throughput gene expression experiments.
  47. (2010). Ovarian cancer pathogenesis: a model in evolution.
  48. (2001). Ovarian surface epithelium: biology, endocrinology, and pathology.
  49. (2009). Palladin contributes to invasive motility in human breast cancer cells.
  50. (2008). Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.
  51. (2009). Phorbol ester-induced podosomes in normal human bronchial epithelial cells.
  52. (2008). Phosphorylation of focal adhesion kinase promotes extravasation of breast cancer cells.
  53. (2006). Protein kinase C (PKC) family in cancer progression.
  54. (1996). Protein kinase C beta II specifically binds to and is activated by F-actin.
  55. (2007). Regulation of membrane trafficking and endocytosis by protein kinase C: emerging role of the pericentrion, a novel protein kinase C-dependent subset of recycling endosomes.
  56. (2005). Regulation of microtubules in cell migration.
  57. (2005). Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model.
  58. (2007). Shaping the actin cytoskeleton using microtubule tips.
  59. (2005). Suppression of cancer phenotypes through a multifunctional actin-binding protein, calponin, that attacks cancer cells and simultaneously protects the host from invasion.
  60. Taketo MM (2007) Adenomatous polyposis coli (APC): a multifunctional tumor suppressor gene.
  61. (2009). The actin cytoskeleton in cancer cell motility.
  62. (2009). The actin cytoskeleton in spindle assembly and positioning.
  63. (2000). The hallmarks of cancer.
  64. (2008). The microfilament system and malignancy.
  65. (1993). The multistep nature of cancer.
  66. (2007). Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma.
  67. (2009). Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices.
  68. (2009). Traffic control: regulation of kinesin motors.
  69. (2009). Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.
  70. (2004). Translocation of protein kinase CbetaII in astrocytes requires organized actin cytoskeleton and is not accompanied by synchronous RACK1 relocation.
  71. (2009). Tyrosine phosphorylation: thirty years and counting.
  72. (2005). Understanding microtubule dynamics for improved cancer therapy.
  73. (2008). Wnt signaling in ovarian tumorigenesis.